NCT04520373View on ClinicalTrials.gov

Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 25, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Spinal Cord InjuriesParalysis
Interventions
OTHER

Best Medical Management: Occupational and Physical Therapy

Observation while undergoing Occupational and Physical Therapy for 6 months

BIOLOGICAL

Autologous, Adipose Derived Mesenchymal Stem Cells

The mesenchymal stem cells will be collected and expanded from the patients' adipose tissue.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04520373 - Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients | Biotech Hunter | Biotech Hunter